Skip to content

Clinical trials

Phase 3 Glioblastoma trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glioblastoma Phase: Phase 3 Country / region: France Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20063
20082
20092
20112
20132
20141
20151
20171
20181
20191
20243
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Recruiting3
Active, not recruiting2
Terminated2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC3
Assistance Publique - Hôpitaux de Paris2
NovoCure Ltd.2
AbbVie1
AstraZeneca1
Bristol-Myers Squibb1
CarThera1
Celldex Therapeutics1
Centre Leon Berard1
Centre Oscar Lambret1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glioblastoma24
Brain Neoplasms8
Gliosarcoma4
Astrocytoma3
Neoplasms3
Central Nervous System Neoplasms2
Glioma2
Edema1
Hypoxia1
Recurrence1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.